1-20 of 31
Peter S. Nelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Michael C. Haffner, Michael J. Morris, Chien-Kuang C. Ding, Erolcan Sayar, Rohit Mehra, Brian Robinson, Lawrence D. True, Martin Gleave, Tamara L. Lotan, Rahul Aggarwal, Jiaoti Huang, Massimo Loda, Peter S. Nelson, Mark A. Rubin, Himisha Beltran
Journal: Clinical Cancer Research
Clin Cancer Res (2024)
https://doi.org/10.1158/1078-0432.CCR-24-2061
Published: 26 November 2024
View article titled, Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Open the PDF for Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies in another window
Includes: Supplementary data
Journal Articles

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Adam G. Sowalsky, Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan, Wei Yuan, Joshua W. Russo, John R. Bright, Nichelle C. Whitlock, Shana Y. Trostel, Anson T. Ku, Radhika A. Patel, Lawrence D. True, Jonathan Welti, Juan M. Jimenez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Antje Neeb, Cynthia T. Sprenger, Amanda Swain, Scott Wilkinson, Fatima Karzai, William L. Dahut, Steven P. Balk, Eva Corey, Peter S. Nelson, Michael C. Haffner, Stephen R. Plymate, Johann S. de Bono, Adam Sharp
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (16): 3509–3525.
https://doi.org/10.1158/1078-0432.CCR-22-0851
Published: 15 August 2022
View article titled, Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Open the PDF for Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer

Ilsa M. Coleman, Navonil DeSarkar, Colm Morrissey, Li Xin, Martine P. Roudier, Erolcan Sayar, Dapei Li, Eva Corey, Michael C. Haffner, Peter S. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3127–3140.
https://doi.org/10.1158/1078-0432.CCR-21-4289
Published: 15 July 2022
View article titled, Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Phillip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin, Nima Sharifi, Alvin M. Matsumoto, Peter S. Nelson, R. Bruce Montgomery
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 6001–6011.
https://doi.org/10.1158/1078-0432.CCR-21-1819
Published: 01 November 2021
View article titled, Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
Open the PDF for Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program

Dae-Hwan Kim, Duanchen Sun, William K. Storck, Katherine Welker Leng, Chelsea Jenkins, Daniel J. Coleman, David Sampson, Xiangnan Guan, Anbarasu Kumaraswamy, Eva S. Rodansky, Joshua A. Urrutia, Jacob A. Schwartzman, Chao Zhang, Himisha Beltran, Mark P. Labrecque, Colm Morrissey, Jared M. Lucas, Ilsa M. Coleman, Peter S. Nelson, Eva Corey, Samuel K. Handelman, Jonathan Z. Sexton, Rahul Aggarwal, Wassim Abida, Felix Y. Feng, Eric J. Small, Daniel E. Spratt, Armand Bankhead, III, Arvind Rao, Emily M. Gesner, Sarah Attwell, Sanjay Lakhotia, Eric Campeau, Joel A. Yates, Zheng Xia, Joshi J. Alumkal
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4923–4936.
https://doi.org/10.1158/1078-0432.CCR-20-4968
Published: 01 September 2021
View article titled, BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Open the PDF for BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program in another window
Includes: Supplementary data
Journal Articles

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Rana R. McKay, Lucia Kwak, Jett P. Crowdis, Jamie M. Sperger, Shuang G. Zhao, Wanling Xie, Lillian Werner, Rosina T. Lis, Zhenwei Zhang, Xiao X. Wei, Joshua M. Lang, Eliezer M. Van Allen, Rupal S. Bhatt, Evan Y. Yu, Peter S. Nelson, Glenn J. Bubley, R. Bruce Montgomery, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3610–3619.
https://doi.org/10.1158/1078-0432.CCR-20-4616
Published: 01 July 2021
View article titled, Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Open the PDF for Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance in another window
Includes: Supplementary data
Journal Articles

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

Diana C. DeLucia, Thomas M. Cardillo, Lisa Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins, Navonil De Sarkar, Ilsa Coleman, Rui M. Gil da Costa, Eva Corey, Lawrence D. True, Michael C. Haffner, Michael T. Schweizer, Colm Morrissey, Peter S. Nelson, John K. Lee
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (3): 759–774.
https://doi.org/10.1158/1078-0432.CCR-20-3396
Published: 01 February 2021
View article titled, Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer
Open the PDF for Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography

Hallie M. Hintz, Joseph P. Gallant, Donald J. Vander Griend, Ilsa M. Coleman, Peter S. Nelson, Aaron M. LeBeau
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (18): 4882–4891.
https://doi.org/10.1158/1078-0432.CCR-20-1358
Published: 15 September 2020
View article titled, Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography
Open the PDF for Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography in another window
Journal Articles

Abstract PR06: Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

Brian R. Winters, Navonil De Sarkar, Sonali Arora, Hamid Bolouri, Sujata Jana, Funda Vakar-Lopez, Heather H. Cheng, Michael T. Schweizer, Evan Y. Yu, Petros Grivas, John K. Lee, Lori Kollath, Sarah K. Holt, Lisa McFerrin, Gavin Ha, Peter S. Nelson, Robert B. Montgomery, Jonathan L. Wright, Hung-Ming Lam, Andrew C. Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): PR06.
https://doi.org/10.1158/1557-3265.BLADDER19-PR06
Published: 03 August 2020
View article titled, Abstract PR06: Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Journal Articles

Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer

Alexandra N. Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, Jared M. Lucas, Arja Kaipainen, Holly M. Nguyen, Daniel Sondheim, Lisha G. Brown, Lawrence D. True, John K. Lee, David MacPherson, Paul Nghiem, Roman Gulati, Colm Morrissey, Eva Corey, Peter S. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1667–1677.
https://doi.org/10.1158/1078-0432.CCR-19-0775
Published: 01 April 2020
View article titled, Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer
Open the PDF for Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer

Paige M. Glumac, Joseph P. Gallant, Mariya Shapovalova, Yingming Li, Paari Murugan, Shilpa Gupta, Ilsa M. Coleman, Peter S. Nelson, Scott M. Dehm, Aaron M. LeBeau
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1054–1064.
https://doi.org/10.1158/1078-0432.CCR-19-1659
Published: 02 March 2020
View article titled, Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer
Open the PDF for Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

Himisha Beltran, Andrew Hruszkewycz, Howard I. Scher, Jeffrey Hildesheim, Jennifer Isaacs, Evan Y. Yu, Kathleen Kelly, Daniel Lin, Adam Dicker, Julia Arnold, Toby Hecht, Max Wicha, Rosalie Sears, David Rowley, Richard White, James L. Gulley, John Lee, Maria Diaz Meco, Eric J. Small, Michael Shen, Karen Knudsen, David W. Goodrich, Tamara Lotan, Amina Zoubeidi, Charles L. Sawyers, Charles M. Rudin, Massimo Loda, Timothy Thompson, Mark A. Rubin, Abdul Tawab-Amiri, William Dahut, Peter S. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 6916–6924.
https://doi.org/10.1158/1078-0432.CCR-19-1423
Published: 02 December 2019
View article titled, The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Open the PDF for The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance in another window
Includes: Supplementary data
Journal Articles

Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer

Elahe A. Mostaghel, Ailin Zhang, Susana Hernandez, Brett T. Marck, Xiaotun Zhang, Daniel Tamae, Heather E. Biehl, Maria Tretiakova, Jon Bartlett, John Burns, Ruth Dumpit, Lisa Ang, Alvin M. Matsumoto, Trevor M. Penning, Steven P. Balk, Colm Morrissey, Eva Corey, Lawrence D. True, Peter S. Nelson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (1): 426–439.
https://doi.org/10.1158/1078-0432.CCR-18-1431
Published: 03 January 2019
View article titled, Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer
Open the PDF for Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer

Elahe A. Mostaghel, Eunpi Cho, Ailin Zhang, Mohammad Alyamani, Arja Kaipainen, Sean Green, Brett T. Marck, Nima Sharifi, Jonathan L. Wright, Roman Gulati, Lawrence D. True, Massimo Loda, Alvin M. Matsumoto, Daniel Tamae, Trevor N. Penning, Steven P. Balk, Phillip W. Kantoff, Peter S. Nelson, Mary-Ellen Taplin, R. Bruce Montgomery
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4592–4601.
https://doi.org/10.1158/1078-0432.CCR-16-2245
Published: 14 August 2017
View article titled, Association of Tissue Abiraterone Levels and <em>SLCO</em> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Open the PDF for Association of Tissue Abiraterone Levels and <em>SLCO</em> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Enzalutamide Prior to Prostatectomy

Bruce Montgomery, Maria S. Tretiakova, Anthony M. Joshua, Martin E. Gleave, Neil Fleshner, Glenn J. Bubley, Elahe A. Mostaghel, Kim N. Chi, Daniel W. Lin, Martin Sanda, William Novotny, Kenneth Wu, Philip W. Kantoff, Brett T. Marck, Stephen Plymate, Steven P. Balk, Peter S. Nelson, Alvin M. Matsumoto, Rosina T. Lis, Adam Kibel, Gabriel P. Haas, Andrew Krivoshik, Alison Hannah, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (9): 2169–2176.
https://doi.org/10.1158/1078-0432.CCR-16-1357
Published: 30 April 2017
View article titled, Neoadjuvant Enzalutamide Prior to Prostatectomy
Open the PDF for Neoadjuvant Enzalutamide Prior to Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

Hung-Ming Lam, Ryan McMullin, Holly M. Nguyen, Ilsa Coleman, Michael Gormley, Roman Gulati, Lisha G. Brown, Sarah K. Holt, Weimin Li, Deborah S. Ricci, Karin Verstraeten, Shibu Thomas, Elahe A. Mostaghel, Peter S. Nelson, Robert L. Vessella, Eva Corey
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (9): 2301–2312.
https://doi.org/10.1158/1078-0432.CCR-16-2054
Published: 30 April 2017
View article titled, Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
Open the PDF for Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts in another window
Includes: Supplementary data
Journal Articles

ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer

Shuai Gao, Huihui Ye, Sean Gerrin, Hongyun Wang, Ankur Sharma, Sen Chen, Akash Patnaik, Adam G. Sowalsky, Olga Voznesensky, Wanting Han, Ziyang Yu, Elahe A. Mostaghel, Peter S. Nelson, Mary-Ellen Taplin, Steven P. Balk, Changmeng Cai
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3672–3682.
https://doi.org/10.1158/1078-0432.CCR-15-2309
Published: 14 July 2016
View article titled, ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer
Open the PDF for ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Xiaotun Zhang, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Jared M. Lucas, Hung-Ming Lam, Ruth Dumpit, Eva Corey, Lisly Chéry, Bryce Lakely, Celestia S. Higano, Bruce Montgomery, Martine Roudier, Paul H. Lange, Peter S. Nelson, Robert L. Vessella, Colm Morrissey
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4698–4708.
https://doi.org/10.1158/1078-0432.CCR-15-0157
Published: 14 October 2015
View article titled, SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
Open the PDF for SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors

Eddy J. Chen, Adam G. Sowalsky, Shuai Gao, Changmeng Cai, Olga Voznesensky, Rachel Schaefer, Massimo Loda, Lawrence D. True, Huihui Ye, Patricia Troncoso, Rosina L. Lis, Philip W. Kantoff, Robert B. Montgomery, Peter S. Nelson, Glenn J. Bubley, Steven P. Balk, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1273–1280.
https://doi.org/10.1158/1078-0432.CCR-14-1220
Published: 12 March 2015
View article titled, Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors
Open the PDF for Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors in another window
Includes: Supplementary data
Journal Articles

IGFBP-5 in the bone and bone marrow is a therapeutic target for metastatic prostate cancer

Chang Xu, Lynn F. Graf, Ladan Fazli, Peter S. Nelson, Stephen R. Plymate, Michael E. Cox, Beverly J. Torok-Storb, Beatrice S. Knudsen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B38.
Published: 15 August 2014
View article titled, IGFBP-5 in the bone and bone marrow is a therapeutic target for metastatic prostate cancer